1350811-66-3

Upstream product

• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 
• 1192546-40-9 4-bromobenzoic acid[⁽¹⁴⁾C-carboxyl] 

Downstream Products

• 855942-99-3 1-(4-bromophenyl)[⁽¹⁴⁾C-carbonyl]ethanone 
• 1316741-74-8 4-acetyl[⁽¹⁴⁾C-carbonyl]benzonitrile 
• 1316741-76-0 4'-(2-bromoacetyl)[⁽¹⁴⁾C-carbony]benzonitrile 
• 1316741-78-2 4-{2-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-[1,2,4]triazol-4-yl-propyl]}(4-[14]C-thiazol-4-yl)-benzonitrile 

Relevant academic research and scientific papers

Carbon-14-and carbon-13-labeled phosphoric acid [2-4-(4-cyanophenyl)- thiazol-2-yl]-(2,4-difluorophenyl)-1-[1,2,4]triazol-4-yl-methylpropoxymethyl] monoester dilysine salt, a prodrug of ravuconazole

4-Bromobenzoic acid [carboxyl-14C] and 4-(2-bromoacetyl) [Ar-13C6]benzonitrile were transformed into the title compounds containing [ring14C-thiazol-4-yl] and [Ar- 13C6-benzonitrile].